Thyroid disease is a favorable prognostic factor in achieving sustained virologic response in chronic hepatitis C undergoing combination therapy: A nested case control study

BACKGROUND: Interferon-α in combination with ribavirin is the current gold standard for treatment of chronic hepatitis C. It is unknown if the development of autoimmune thyroid disease (TD) during treatment confers an improved chance of achieving sustained virologic response. The aim of this study i...

Descripción completa

Detalles Bibliográficos
Autores principales: Tran, Huy A, Jones, Tracey L, Gibson, Robert, Reeves, Glenn EM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123561/
https://www.ncbi.nlm.nih.gov/pubmed/21605462
http://dx.doi.org/10.1186/1472-6823-11-10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123561/
https://www.ncbi.nlm.nih.gov/pubmed/21605462
http://dx.doi.org/10.1186/1472-6823-11-10

Ejemplares similares